致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Biotinylated Human LILRA5/CD85f/ILT11, Avi-His-tag
目录号 NBL-242348
别名 LILRA5/CD85f/ILT11; CD85; CD85f; ILT11; ILT-11; ILT11CD85f; LILRA5; LILRB7; LIR9; LIR-9
外观 see COA
分子量 Gly42-Arg268
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 A6NI73-1
备注2
目录号 规格 价格 库存状态  
NBL-242348-100ug 100ug Inquire Inquire
NBL-242348-1mg 1mg Inquire Inquire
NBL-242348-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Biotinylated Human LILRA5/CD85f/ILT11, Avi-His-tag


Catalog#:

NBL-242348


Description:

NebuSelect™ Recombinant Biotinylated Human LILRA5/CD85f/ILT11, Avi-His-tag(Cat#NBL-242348) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly42-Arg268.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 28.2 kDa. Due to glycosylation, the protein migrates to 38-50 kDa based on Bis-Tris PAGE result.


Target Name:

LILRA5/CD85f/ILT11; CD85; CD85f; ILT11; ILT-11; ILT11CD85f; LILRA5; LILRB7; LIR9; LIR-9


Target Information:

The leukocyte immunoglobulin-like receptors (LILR) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIRs). Human LILRA5, also known as ILT11, LIR-9, and CD85f, consists of a 227 amino acid (aa) extracellular domain (ECD), a 21 aa transmembrane segment, and a 10 aa cytoplasmic tail. LILRA5 may play a role in triggering innate immune responses. Does not seem to play a role for any class I MHC antigen recognition.


Amino Acid Sequence: 

Gly42-Arg268


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品